Business Description
Staar Surgical Co
NAICS : 339115
SIC : 3851
ISIN : US8523123052
Share Class Description:
FRA:SR3: Ordinary SharesDescription
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.9 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 1.27 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 10 | |||||
| Beneish M-Score | -2.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.1 | |||||
| 3-Year EBITDA Growth Rate | 48.3 | |||||
| 3-Year EPS without NRI Growth Rate | 61.9 | |||||
| 3-Year Book Growth Rate | 23 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 29.51 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.39 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.44 | |||||
| 9-Day RSI | 58.69 | |||||
| 14-Day RSI | 52.72 | |||||
| 6-1 Month Momentum % | -28.46 | |||||
| 12-1 Month Momentum % | -4.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.99 | |||||
| Quick Ratio | 5.38 | |||||
| Cash Ratio | 3.56 | |||||
| Days Inventory | 185.52 | |||||
| Days Sales Outstanding | 100.55 | |||||
| Days Payable | 73.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -0.18 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.73 | |||||
| Operating Margin % | 7.53 | |||||
| Net Margin % | 6.38 | |||||
| FCF Margin % | 7.67 | |||||
| ROE % | 5.46 | |||||
| ROA % | 4.35 | |||||
| ROIC % | 6.68 | |||||
| 3-Year ROIIC % | 8.71 | |||||
| ROC (Joel Greenblatt) % | 13.34 | |||||
| ROCE % | 5.88 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 71.5 | |||||
| Forward PE Ratio | 38.71 | |||||
| PE Ratio without NRI | 76.73 | |||||
| Shiller PE Ratio | 156.43 | |||||
| Price-to-Owner-Earnings | 224.71 | |||||
| PEG Ratio | 2.17 | |||||
| PS Ratio | 4.56 | |||||
| PB Ratio | 3.62 | |||||
| Price-to-Tangible-Book | 3.7 | |||||
| Price-to-Free-Cash-Flow | 58.15 | |||||
| Price-to-Operating-Cash-Flow | 32.77 | |||||
| EV-to-EBIT | 48.82 | |||||
| EV-to-EBITDA | 39.92 | |||||
| EV-to-Forward-EBITDA | 45.55 | |||||
| EV-to-Revenue | 3.68 | |||||
| EV-to-Forward-Revenue | 3.3 | |||||
| EV-to-FCF | 51.5 | |||||
| Price-to-Projected-FCF | 2.99 | |||||
| Price-to-Median-PS-Value | 0.52 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.12 | |||||
| Price-to-Graham-Number | 3.58 | |||||
| Price-to-Net-Current-Asset-Value | 5.48 | |||||
| Price-to-Net-Cash | 12.42 | |||||
| Earnings Yield (Greenblatt) % | 2.05 | |||||
| FCF Yield % | 1.82 | |||||
| Forward Rate of Return (Yacktman) % | 20.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Staar Surgical Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 312.906 | ||
| EPS (TTM) (€) | 0.402 | ||
| Beta | 0.63 | ||
| Volatility % | 63.82 | ||
| 14-Day RSI | 52.72 | ||
| 14-Day ATR (€) | 0.651466 | ||
| 20-Day SMA (€) | 27.885 | ||
| 12-1 Month Momentum % | -4.98 | ||
| 52-Week Range (€) | 25.6 - 47.99 | ||
| Shares Outstanding (Mil) | 49.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Staar Surgical Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Staar Surgical Co Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Staar Surgical Co Frequently Asked Questions
What is Staar Surgical Co(FRA:SR3)'s stock price today?
The current price of FRA:SR3 is €28.69. The 52 week high of FRA:SR3 is €47.99 and 52 week low is €25.60.
When is next earnings date of Staar Surgical Co(FRA:SR3)?
The next earnings date of Staar Surgical Co(FRA:SR3) is 2025-02-26 Est..
Does Staar Surgical Co(FRA:SR3) pay dividends? If so, how much?
Staar Surgical Co(FRA:SR3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers